Launch economics: a new lung treatment in Germany
New to this industry?Start with its one-minute summary: Pharma, biotech and medtech
The prompt
A fictional mid-sized pharma company plans to launch a new treatment for a chronic lung disease in Germany. About 50,000 patients are eligible, and it expects to treat 20 percent of them at peak. The net price (after discounts) is EUR 12,000 per patient per year. Making the drug costs 10 percent of net sales, and the medical and sales team costs EUR 30 million a year. What are peak sales and peak yearly contribution after the sales team?
Practice with a partner
1. Send the interviewer link to a friend. They read the case aloud and hold the answers.
2. You open the candidate view: you see only the prompt, a timer and a notes box.
3. Speak the case out loud. Your partner shares data when you ask, then scores you with the rubric.
Interviewer view
For the person running the case
Candidate view
For the person answering the case
Clarifying questions, with the interviewer's answers
My notes on this case
0 of 5,000 characters. Saves automatically.